Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mitochondrial Fission Pathway is a fundamental cellular process that regulates mitochondrial morphology and network structure. It is crucial for maintaining cellular homeostasis, enabling metabolic adaptation, and facilitating quality control through mitophagy and removal of damaged mitochondria. Key components include Dynamin-related protein 1 (Drp1), Mitochondrial fission factor (Mff), and Fission 1 protein (Fis1). Dysregulation of this pathway has been implicated in various pathological conditions, including cancer, neurodegenerative diseases, and cardiovascular disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Fission Pathway.